Skip to main content
. 2022 Sep 12;28(10):2155–2161. doi: 10.1038/s41591-022-01962-5

Fig. 2. Clinical outcomes in patients who had surgical resection and whose tumors did not have known EGFR or ALK alterations.

Fig. 2

a, Pathological response (n = 143). Pathological regression is defined as percentage viable tumor cells – 100%. b, DFS by MPR status in patients with R0 resections (n = 137). c, OS by MPR status in patients with R0 resections (n = 137). HR, hazard ratio.